Permeability properties of tumor surrogate blood vessels induced by VEGF-A
- PMID: 16732297
- DOI: 10.1038/labinvest.3700436
Permeability properties of tumor surrogate blood vessels induced by VEGF-A
Abstract
Malignant tumors generate new blood vessels by secreting growth factors, particularly members of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) family. Overall, the new blood vessels that form are hyperpermeable to plasma proteins, a property that is thought to be important for generating new stroma. However, tumor blood vessels are structurally heterogeneous and include microvessels of at least the following distinct types: mother vessels (MV), glomeruloid microvascular proliferations (GMP), arterio-venous-like vascular malformations and capillaries. Our goal was to determine whether macromolecular tracers leaked from all or from only a subset of these vessel types and to elucidate the extravasation pathways. As blood vessels are only a minor component of tumors, and therefore, difficult to study in situ, we used an adenoviral vector to express VEGF-A164, the most important member of the VPF/VEGF family, in mouse tissues. So expressed, VEGF-A164 induces large numbers of surrogate vessels of each type found in tumors in a highly reproducible manner. Overall permeability to plasma proteins was assessed qualitatively with Evan's blue dye and quantitatively with a dual tracer method employing radioactive albumin. Leaky vessels were identified by confocal microscopy (FITC-dextran) and by electron microscopy (ferritin). MV, and to a lesser extent GMP, were found to be hyperpermeable but capillaries and vascular malformations were not. Ferritin extravasated primarily by two trans-cellular routes, vesiculo-vacuolar organelles (VVOs) and fenestrae. This occurred despite a considerable reduction in VVO frequency as VVO membranes translocated to the plasma membrane during MV formation. However, reduction in the number and complexity of VVOs was offset by extensive endothelial cell thinning and a greatly shortened extravasation pathway. Extrapolating these findings to tumors predicts that only a subset of tumor vessels, MV and GMP, is hyperpermeable, and that measures of overall vessel permeability greatly underestimate the permeability of individual MV and GMP.
Similar articles
-
Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin.J Exp Med. 1996 May 1;183(5):1981-6. doi: 10.1084/jem.183.5.1981. J Exp Med. 1996. PMID: 8642308 Free PMC article.
-
Different pathways of macromolecule extravasation from hyperpermeable tumor vessels.Microvasc Res. 2000 Jan;59(1):24-37. doi: 10.1006/mvre.1999.2207. Microvasc Res. 2000. PMID: 10625568
-
Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels.Lab Invest. 1992 Nov;67(5):596-607. Lab Invest. 1992. PMID: 1279271
-
Pathways of macromolecular extravasation across microvascular endothelium in response to VPF/VEGF and other vasoactive mediators.Microcirculation. 1999 Mar;6(1):23-44. Microcirculation. 1999. PMID: 10100187 Review.
-
Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.Am J Pathol. 1995 May;146(5):1029-39. Am J Pathol. 1995. PMID: 7538264 Free PMC article. Review.
Cited by
-
Modelling the complex nature of the tumor microenvironment: 3D tumor spheroids as an evolving tool.J Biomed Sci. 2024 Jan 23;31(1):13. doi: 10.1186/s12929-024-00997-9. J Biomed Sci. 2024. PMID: 38254117 Free PMC article. Review.
-
Principles of Nanoparticle Delivery to Solid Tumors.BME Front. 2023 Mar 31;4:0016. doi: 10.34133/bmef.0016. eCollection 2023. BME Front. 2023. PMID: 37849661 Free PMC article. Review.
-
Cross-scale tracing of nanoparticles and tumors at the single-cell level using the whole-lung atlas.Sci Adv. 2023 Aug 2;9(31):eadh7779. doi: 10.1126/sciadv.adh7779. Epub 2023 Aug 2. Sci Adv. 2023. PMID: 37531437 Free PMC article.
-
Biology and therapeutic targeting of vascular endothelial growth factor A.Nat Rev Mol Cell Biol. 2023 Nov;24(11):816-834. doi: 10.1038/s41580-023-00631-w. Epub 2023 Jul 25. Nat Rev Mol Cell Biol. 2023. PMID: 37491579 Review.
-
The role of PLVAP in endothelial cells.Cell Tissue Res. 2023 May;392(2):393-412. doi: 10.1007/s00441-023-03741-1. Epub 2023 Feb 13. Cell Tissue Res. 2023. PMID: 36781482 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
